FDA Import Refusal AEK-8128237-6/41/1 — CIPLA LTD.
The FDA refused shipment AEK-8128237-6/41/1 from CIPLA LTD. (India) on Jan 21, 2025. The refused product falls under Drugs and Biologics — PIPERAZINE (ANTHELMINTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 21, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60WCY26 PIPERAZINE (ANTHELMINTIC)
- Charges
- 75